alexa Cabazitaxel | List of High Impact Articles | PPts | Journals | Videos

Journal of Prostate Cancer

Cabazitaxel

Search results for
Cabazitaxel

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Relevant Topics

Cabazitaxel is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug and classified as a "taxane derivitive" and an "anti-microtubule agent." It is approved for treatment for treatment of patients with castrate resistant metastatic prostate cancer previously treated with a docetaxel-containing treatment regimen.

Nausea: feeling of need to vomit, Constipation: hardened feces , delayed passage of feces . Low-blood count: decrease in white and red blood count for temporarily, Fever: if fever is above 100.4 F consult doctor.

Related Journals of Cabazitaxel

Journal of Prostate Cancer, Journal of Cancer Science & Therapy, Dovepress, European Journal of Hospital Pharmacy, Indo American Journal of Pharmaceutical Research

Cabazitaxel

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords